172 related articles for article (PubMed ID: 26117977)
1. Perinatal outcome in women with inflammatory bowel disease.
Piotr W; Brucka-Kaczor A; Ewelina L; Przemysław O; Agnieszka PD
Ginekol Pol; 2015 May; 86(5):376-82. PubMed ID: 26117977
[TBL] [Abstract][Full Text] [Related]
2. Maternal and fetal parameters including umbilical artery PI and fibrinogen/CRP ratio as predictive factors of perinatal outcome in women with HELLP syndrome.
Brucka-Kaczor A; Woźniak P; Litwińska E; Piotr-Dolińska A; Oszukowski P
Ginekol Pol; 2015 Mar; 86(3):176-81. PubMed ID: 25920306
[TBL] [Abstract][Full Text] [Related]
3. Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab.
Moens A; van Hoeve K; Humblet E; Rahier JF; Bossuyt P; Dewit S; Franchimont D; Macken E; Nijs J; Posen A; Strubbe B; Van Hootegem A; Van Moerkercke W; Vermeire S; Ferrante M;
J Crohns Colitis; 2019 Jan; 13(1):12-18. PubMed ID: 30281093
[TBL] [Abstract][Full Text] [Related]
4. The concentrations of bile acids and erythropoietin in pregnant women with intrahepatic cholestasis and the state of the fetus and newborn.
Kowalska-Kańka A; Maciejewski T; Niemiec KT
Med Wieku Rozwoj; 2013; 17(3):232-45. PubMed ID: 24296447
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease: risk factors for adverse pregnancy outcome and the impact of maternal weight gain.
Oron G; Yogev Y; Shcolnick S; Hod M; Fraser G; Wiznitzer A; Melamed N
J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2256-60. PubMed ID: 22524421
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study.
Moens A; van der Woude CJ; Julsgaard M; Humblet E; Sheridan J; Baumgart DC; Gilletta De Saint-Joseph C; Nancey S; Rahier JF; Bossuyt P; Cremer A; Dewit S; Eriksson C; Hoentjen F; Krause T; Louis E; Macken E; Milenkovic Z; Nijs J; Posen A; Van Hootegem A; Van Moerkercke W; Vermeire S; Bar-Gil Shitrit A; Ferrante M
Aliment Pharmacol Ther; 2020 Jan; 51(1):129-138. PubMed ID: 31692017
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with meta-analysis.
Mozaffari S; Abdolghaffari AH; Nikfar S; Abdollahi M
Hum Exp Toxicol; 2015 May; 34(5):445-59. PubMed ID: 25378092
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California.
Mahadevan U; Sandborn WJ; Li DK; Hakimian S; Kane S; Corley DA
Gastroenterology; 2007 Oct; 133(4):1106-12. PubMed ID: 17764676
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory bowel disease in pregnancy: a population-based study of prevalence and pregnancy outcomes.
Shand AW; Chen JS; Selby W; Solomon M; Roberts CL
BJOG; 2016 Oct; 123(11):1862-70. PubMed ID: 26924786
[TBL] [Abstract][Full Text] [Related]
10. A national study of pregnancy-related maternal and fetal outcomes in women with inflammatory bowel disease.
Tarar ZI; Farooq U; Zafar MU; Saleem S; Nawaz A; Kamal F; Ghous G; Inayat F; Ghouri YA
Int J Colorectal Dis; 2022 Jul; 37(7):1535-1543. PubMed ID: 35612619
[TBL] [Abstract][Full Text] [Related]
11. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
[TBL] [Abstract][Full Text] [Related]
12. Antenatal Management for Women with Inflammatory Bowel Disease: Experience from Our 'IBD MOM' Clinic.
Shitrit AB; Cohen Y; Hassin O; Ya'acov AB; Farkash R; Koslowsky B; Milgrom Y; Livovsky DM; Samueloff A; Goldin E; Grisaru-Granovsky S
Dig Dis Sci; 2018 Jul; 63(7):1774-1781. PubMed ID: 29626275
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006.
Bortoli A; Pedersen N; Duricova D; D'Inca R; Gionchetti P; Panelli MR; Ardizzone S; Sanroman AL; Gisbert JP; Arena I; Riegler G; Marrollo M; Valpiani D; Corbellini A; Segato S; Castiglione F; Munkholm P;
Aliment Pharmacol Ther; 2011 Oct; 34(7):724-34. PubMed ID: 21815900
[TBL] [Abstract][Full Text] [Related]
14. Intrapartum corticosteroid use significantly increases the risk of gestational diabetes in women with inflammatory bowel disease.
Leung YP; Kaplan GG; Coward S; Tanyingoh D; Kaplan BJ; Johnston DW; Barkema HW; Ghosh S; Panaccione R; Seow CH; ;
J Crohns Colitis; 2015 Mar; 9(3):223-30. PubMed ID: 25576754
[TBL] [Abstract][Full Text] [Related]
15. Maternal inflammatory bowel disease has short and long-term effects on the health of their offspring: a multicenter study in Israel.
Dotan I; Alper A; Rachmilewitz D; Israeli E; Odes S; Chermesh I; Naftali T; Fraser G; Shitrit AB; Peles V; Reif S
J Crohns Colitis; 2013 Aug; 7(7):542-50. PubMed ID: 23036507
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes.
Boyd HA; Basit S; Harpsøe MC; Wohlfahrt J; Jess T
PLoS One; 2015; 10(6):e0129567. PubMed ID: 26083614
[TBL] [Abstract][Full Text] [Related]
17. The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.
de Lima-Karagiannis A; Zelinkova-Detkova Z; van der Woude CJ
Am J Gastroenterol; 2016 Sep; 111(9):1305-12. PubMed ID: 27349339
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory bowel disease and preterm delivery.
Elbaz G; Fich A; Levy A; Holcberg G; Sheiner E
Int J Gynaecol Obstet; 2005 Sep; 90(3):193-7. PubMed ID: 16043179
[TBL] [Abstract][Full Text] [Related]
19. Is safety infliximb during pregnancy in patients with inflammatory bowel disease?
Argüelles-Arias F; Castro-Laria L; Barreiro-de Acosta M; García-Sánchez MV; Guerrero-Jiménez P; Gómez-García MR; Cordero-Ruiz P; Iglesias-Flores E; Gómez-Camacho F; Domínguez-Muñoz EJ; Herrerías-Gutiérrez JM
Rev Esp Enferm Dig; 2012 Feb; 104(2):59-64. PubMed ID: 22372798
[TBL] [Abstract][Full Text] [Related]
20. The Risk of Adverse Neonatal Outcomes With Maternal Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Leung KK; Tandon P; Govardhanam V; Maxwell C; Huang V
Inflamm Bowel Dis; 2021 Mar; 27(4):550-562. PubMed ID: 32469057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
